Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Will New Weight-Loss Drugs Change Your Health Journey?

Eli Lilly and Company has announced plans to invest over $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania. This facility will focus on producing next-generation weight-loss medications, including retatrutide, which targets multiple hormone receptors to aid in weight management. The project is expected to create more than 2,800 jobs, including 850 high-value positions such as engineers and lab technicians, while also generating around 2,000 construction jobs during its development.

This investment is significant for anyone interested in healthy aging and weight management. With obesity linked to various health issues, including diabetes and heart disease, the availability of innovative weight-loss treatments could provide new options for individuals looking to improve their health and longevity. The new facility aims to increase access to these therapies, potentially benefiting many people who struggle with weight-related health challenges.

The research and development of retatrutide and similar treatments are still in the early stages, with the facility expected to become operational by 2031. While the investment is promising, it is important to note that the effectiveness and safety of these new medications have yet to be fully established in large-scale human trials. As such, it’s wise to stay informed about these developments while also considering current weight management strategies.

In the meantime, if you’re looking to manage your weight and improve your health, consider focusing on a balanced diet, regular physical activity, and consulting healthcare professionals for personalized advice. These foundational steps can support your wellness journey as new treatments become available.

Source: investor.lilly.com